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ABSTRACT
Background: Saturated fatty acid (SFA) intake increases plasma
LDL-cholesterol concentrations; therefore, intake should be re-
duced to prevent coronary heart disease (CHD). Lower habitual
intakes of SFAs, however, require substitution of other macronu-
trients to maintain energy balance.
Objective: We investigated associations between energy intake from
monounsaturated fatty acids (MUFAs), polyunsaturated fatty acids
(PUFAs), and carbohydrates and risk of CHD while assessing the
potential effect-modifying role of sex and age. Using substitution mod-
els, our aim was to clarify whether energy from unsaturated fatty acids
or carbohydrates should replace energy from SFAs to prevent CHD.
Design: This was a follow-up study in which data from 11 American
and European cohort studies were pooled. The outcome measure was
incident CHD.
Results: During 4–10 y of follow-up, 5249 coronary events and 2155
coronary deaths occurred among 344,696 persons. For a 5% lower
energy intake from SFAs and a concomitant higher energy intake from
PUFAs, there was a significant inverse association between PUFAs and
risk of coronary events (hazard ratio: 0.87; 95% CI: 0.77, 0.97); the
hazard ratio for coronary deaths was 0.74 (95% CI: 0.61, 0.89). For
a 5% lower energy intake from SFAs and a concomitant higher energy
intake from carbohydrates, there was a modest significant direct asso-
ciation between carbohydrates and coronary events (hazard ratio: 1.07;
95% CI: 1.01, 1.14); the hazard ratio for coronary deaths was 0.96
(95% CI: 0.82, 1.13). MUFA intake was not associated with CHD. No
effect modification by sex or age was found.
Conclusion: The associations suggest that replacing SFAs with
PUFAs rather than MUFAs or carbohydrates prevents CHD over
a wide range of intakes. Am J Clin Nutr 2009;89:1425–32.
INTRODUCTION
The effect of dietary fat on risk of coronary heart disease
(CHD) is at least partially mediated by the effect of dietary fat on
plasma lipids (1). National health organizations (2, 3) recom-
mend dietary changes that reduce intakes of saturated fatty acids
(SFAs) to prevent CHD. The rationale is to reduce the LDL-
cholesterol concentration in plasma. A lower habitual intake of
SFAs requires substitution of other macronutrients to maintain
the energy balance. The question remains whether a lower intake
of SFAs should be replaced with a higher intake of unsaturated
fatty acids or a higher intake of carbohydrates.
One follow-up study examined the risk of CHD with a lower
energy intake from SFAs and a concomitant higher energy intake
from unsaturated fatty acids or carbohydrates (4). The results
from that study showed that replacing SFAs with unsaturated
fatty acids was inversely associated with risk of CHD, whereas
replacing SFAs with carbohydrates was not associated with risk
of CHD. In another follow-up study, it was found that sex and
age modified the association between intakes of SFAs and risk of
CHD (5). In that study, SFA intake was strongly directly asso-
ciated with risk of CHD among women aged ,60 y but not
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among women aged 60 y. Among men, the results indicated
a direct association between SFA intake and risk of CHD among
men aged ,60 y but not among men aged 60 y. Effect mod-
ification by sex and age may be due to hormonal differences;
female sex hormones have estrogenic activity and male sex
hormones have androgenic activity. Furthermore, after meno-
pause the female sex hormones decline. Moreover, effect mod-
ification by sex and age may be due to differences in the
underlying hazard functions.
In the present study, we pooled data from 11 American and
European studies included in the Pooling Project of Cohort
Studies on Diet and Coronary Disease and investigated associ-
ations between energy intakes from unsaturated fatty acids and
carbohydrates and the risk of CHD while assessing the potential
effect-modifying role of sex and age. Using substitution models, our
objective was to clarify whether energy intake from unsaturated
fatty acids or carbohydrates should replace energy intake from
SFAs to prevent CHD. Pooling data allows study of associations
between major types of dietary fat and risk of CHD in different
populations with different diets and over a wide range of intakes.
SUBJECTS AND METHODS
Study population
The criteria for inclusion of studies in the Pooling Project of
Cohort Studies on Diet and Coronary Disease were as follows: 1)
published follow-up study with 150 incident coronary events, 2)
availability of usual dietary intake, and 3) a validation or re-
peatability study of the diet-assessment method used (6). Through
literature searches and inquiries with experts in the field, 14
American and European cohort studies were identified and inves-
tigators of 11 studies agreed to include their data in the project (6).
The included studies are presented in Table 1 (4, 5, 7–15). The
follow-up of the Nurses’ Health Study was divided into 2 periods
for analysis to take advantage of the repeated assessments of dietary
intake and the long follow-up. Following the underlying theory of
survival data, blocks of person-time in different periods are statis-
tically independent, even if derived from the same persons (16).
Two of the 11 included studies were randomized primary pre-
vention studies: the Alpha-Tocopherol and Beta-Carotene Cancer
Prevention Study (ATBC) and the Women’s Health Study (WHS).
The treatments were a-tocopherol, b-carotene, or both in the ATBC
and a-tocopherol and aspirin in the WHS.
Criteria for exclusion of persons from the population at risk
were as follows: age ,35 y; history of cardiovascular disease,
diabetes, or cancer (other than nonmelanoma skin cancer); and
extreme energy intake (ie, . or ,3 SDs from the study-specific
log-transformed mean energy intake of the population). The final
population consisted of 344,696 persons (71% women; Table 1).
Exposure measures
Dietary intake was determined at baseline by using a food-
frequency questionnaire or a dietary history interview (Table 1).
The validation and repeatability of the diet-assessment methods
were evaluated and were found reasonable for population studies
of the nutrients of interest. Total energy intake was calculated as
the sum of energy intake derived from fat, carbohydrates, and
protein. Derived exposure measures were dietary intake of
monounsaturated fatty acids (MUFAs; primarily n29 oleic acid,
also known as omega-9 oleic acid), polyunsaturated fatty acids
(PUFAs; including n23 and n26 fatty acids, also known as
omega-3 and omega-6 fatty acids; primarily n26 linoleic acid),
and carbohydrates. The MUFA and PUFA for which the data are
reported in the Israeli Ischemic Heart Disease Study (IIHD)
were the n29 MUFA oleic acid and the n26 PUFA linoleic
acid.
Outcome measures
The outcome measures were fatal CHD (including sudden
death) and nonfatal myocardial infarction. Standardized criteria
were used to ascertain events of fatal and nonfatal myocardial
infarction (6). Because the IIHD and Iowa Women’s Health
Study (IWHS) had only self-reported data on nonfatal CHD, we
used only fatal CHD events from these studies.
Statistical analyses
Within each study, hazard ratios (HRs) with 95% CIs for the
incidence of a coronary event and of mortality from CHD were
calculated by using Cox proportional hazards regression with
time in study (y) as the time metric. The observation time for each
participant was defined as the number of months from the date on
which information on diet was obtained until CHD occurrence,
death of another cause, disappearance, or end of follow-up,
whichever came first. Studies with follow-up periods .10 y were
truncated to reduce possible effect modification by time.
Two models were used to investigate whether energy intake
from unsaturated fatty acids or carbohydrates should replace the
energy intake from SFAs to prevent coronary events. Model 1
included intakes of MUFAs, PUFAs, trans fatty acids (TFAs),
carbohydrates, and protein expressed as percentages of total en-
ergy intake (as continuous variables) and total energy intake (kcal/d;
as a continuous variable). Age at baseline (y) and the calendar year
in which the baseline questionnaire was returned were entered into
the model through the strata statement; thus, assuming the same
effect for the variable of interest but allowing the underlying
hazard functions to differ with respect to age and time of collection
of dietary information. Model 2 included variables in model 1 and
CHD risk factors measured at baseline: smoking (never smokers,
former smokers, and current smokers of 1–4, 5–14, 15–24, or
25 cigarettes/d), body mass index (in kg/m2; ,23, 23 to ,25, 25
to ,27.5, 27.5 to ,30, or 30), physical activity (levels 1–5),
highest attained educational level (,high school, high school,
or .high school), alcohol intake (0, 0 to ,5, 5 to ,10, 10 to
,15, 15 to ,30, 30 to ,50, or 50 g/d), history of hypertension
(yes or no), and energy-adjusted quintiles of fiber intake (g/d) and
cholesterol intake (mg/d). Every variable was standardized across
studies to the extent possible (6). A missing indicator variable was
created for each categorical variable. Adjustment for treatment
group was done in the ATBC (placebo or nonplacebo), but this was
not possible in the ongoing WHS because of confidentiality issues.
The estimated HRs for unsaturated fatty acids and carbohydrates
can be interpreted as the estimated differences in risk of a 5%
lower energy intake from SFAs and a concomitant higher energy
intake from unsaturated fatty acids and carbohydrates, re-
spectively. In other words the results may be interpreted as re-
placing SFAs with unsaturated fatty acids or carbohydrates.
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Methods for pooling the study-specific HRs followed those
described by Smith-Warner et al (17). The study-specific logs of
HRs were weighted by the inverse of their variances, and
a pooled (combined) estimate of the HRs was computed by using
a random-effects model. Evidence for between-studies hetero-
geneity among the study-specific HRs was assessed by using the
estimated between-studies variance component Q statistic.
To evaluate potential effect modification by age, the study
population was divided into 2 age groups in further analyses: ,60
y at entry and 60 y at entry. Effect modification by sex and age
was investigated by including a cross-product interaction term
between the exposure variable and sex or age. Pooled P values for
the test of interaction were calculated by using squared Wald
statistics by pooling the study-specific interaction log HRs and
dividing by the square of the SE of the pooled interaction term.
The resulting statistic was referred to a chi-square distribution
with 1 df.
The proportional hazards assumption was checked by in-
cluding a cross-product interaction term between the exposure
variable and the stratifying variable age (y). We tested the ex-
posure variables for nonlinearity in a spline regression model.
The analyses were performed by using SAS statistical software,
release 9.1 (SAS Institute Inc, Cary, NC) and Stata statistical
software, release 9.0 (Stata Corporation, College Station, TX).
RESULTS
Characteristics of the cohort studies are given in Table 1.
During 4–10 y of follow-up, 5249 coronary events and 2155
coronary deaths occurred among 344,696 persons (71% women;
Table 1).
Combined HRs and 95% CIs for coronary events and deaths for
a 5% lower energy intake from SFAs and a concomitant higher
energy intake from unsaturated fatty acids or carbohydrates are
shown in Table 2. There was an indication of an overall direct
association between substitution of MUFAs and risk of coronary
events (HR: 1.19; 95% CI: 1.00, 1.42), but not between sub-
stitution of MUFAs and risk of coronary deaths (HR: 1.01; 95%
CI: 0.73, 1.41; Table 2). There was an overall significant inverse
association between substitution of PUFAs and risk of coronary
events (HR: 0.87; 95% CI: 0.77, 0.97) and between substitution of
PUFAs and risk of coronary deaths (HR: 0.74; 95% CI: 0.61, 0.89;
Table 2). There was an overall significant direct association be-
tween substitution of carbohydrates and risk of coronary events
(HR: 1.07; 95% CI: 1.01, 1.14) but not between substitution of
carbohydrates and risk of coronary deaths (HR: 0.96; 95% CI:
0.82, 1.13; Table 2). There was no effect modification by sex
(Table 2). Study-specific and combined HRs and 95% CIs for
coronary events and deaths for a 5% lower energy intake from
SFAs and a concomitant higher energy intake from PUFAs or
carbohydrates are shown in Figure 1. Combined HRs and 95%
CIs for coronary events and deaths among persons aged ,60 y at
entry and persons aged 60 y at entry are shown in Table 3.
Among women aged ,60 y, there was a borderline significant
inverse association between substitution of PUFAs and risk of
coronary events (HR: 0.73; 95% CI: 0.53, 1.01); among women
aged 60 y, the HR was 1.22 (95% CI: 0.84, 1.77; Table 3).
Among men aged ,60 y, the HR was 0.90 (95% CI: 0.72, 1.12) for
PUFAs and coronary events; among men aged60 y, the HR was
0.81 (95% CI: 0.65, 1.01; Table 3). Among women aged ,60 y,
there was a strong significant inverse association between sub-
stitution of PUFAs and coronary deaths (HR: 0.49; 95% CI: 0.29,
0.83); among women aged60 y, the HR was 0.73 (95% CI: 0.48,
1.11; Table 3). Among men aged ,60 y, the HR was 0.83 (95% CI:
0.61, 1.13) for PUFAs and coronary deaths; among men aged60
y, the HR was 0.78 (95% CI: 0.54, 1.12; Table 3). There was no
effect modification by age among women or men (Table 3). There
was no effect modification by sex among persons aged ,60 y or
60 y (data not shown).
DISCUSSION
This study suggests that to prevent CHD, SFA intake should be
replaced with PUFA intake rather than MUFA or carbohydrate
intake. However, the effects of substitution of carbohydrates may
vary depending on the quality of the carbohydrates consumed.
Several classifications may be relevant to CHD risk, including
1) dietary fiber content (6), 2) extent of processing (whole com-
pared with refined grain) (18), or 3) glycemic index (19). In this
study, only type of fat, not type of carbohydrates, was consid-
ered. The estimated HRs for carbohydrate intake in this study,
however, may reflect variation in glycemic carbohydrate intake as
variation in fiber intake was taken into account in the analyses.
An advantage of the Pooling Project of Cohort Studies on Diet
and Coronary Disease is that publication bias is reduced because of
the inclusion of cohort studies [Adventis Health Study (AHS),
Atherosclerosis Risk in Communities Study (ARIC), Finnish
Mobile Clinic Health Study (FMC), IWHS, Västerbotten In-
terventionProgram(VIP), andWHS]fromwhichresults ondietary
fats and risk of CHD have not been published. Moreover, pooling
data allowed studying this topic in different populations with
different diets and over a wide range of intakes (Table 1). Other
advantages included the ability to evaluate whether the exposure-
disease association is modified by other risk factors.
Information bias is unlikely to have affected the present results
as diagnoses were established independently of the dietary recalls
of the participants. Dietary intake was determined by using a food-
frequency questionnaire or a dietary history interview, which may
reflect habitual eating pattern. Only baseline information re-
garding dietary habits was available. The lack of repeated as-
sessment of dietary intake excludes possible analytic approaches
to reduce random measurement error. Generally, measurement
error leads to underestimation of the true risk and to loss of sta-
tistical power for testing associations (under the assumption that
measurement error is nondifferential with regard to the outcome).
Using calibrated dietary data would provide information on range
of absolute intakes by reducing systematic measurement errors
across studies in the estimation of total food intake. In this study,
however, exposure measures were expressed relative to total en-
ergy intake, which substantially reduces errors in the estimation
of total food intake. Additional confounding from other CHD
risk factors not taken into account remains a possible explanation
for the observed associations. In this study, additional adjustment
for suggested dietary CHD risk factors (vitamin E, vitamin C, and
folicacid)didnotchange theHRs,but theCIsbecameslightlywider.
Three randomized trials of dietary fat intake and risk of CHD
that evaluated primary preventive interventions have been con-
ducted (20–22). In 2 of these 3 trials, total fat intake was not
reduced, but SFA intake was replaced with PUFA intake. In the
Los Angeles Veterans Administration Trial (20), the incidence
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of CHD events manifested by sudden death or myocardial in-
farction (MI) was lower in the intervention group than in the
control group after 8 y of follow-up, although not statistically
significant. In the Minnesota Coronary Survey (21), no differ-
ence between the intervention and control groups was found for
CHD events manifested by sudden death or MI. However, the
study was relatively short in duration (4.5 y), and the achieved
PUFA intake to SFA intake ratio (1.6) in the intervention group
was far below the specified goal (2.5). No randomized trials
have reported the effects of replacing SFA intake with carbo-
hydrate intake on CHD risk. The Women’s Health Initiative
Dietary Modification Trial, however, has reported the effects of
reducing total fat intake and increasing vegetable and fruit in-
take on CHD risk (22). Over 8.1 y, the dietary intervention did
not reduce the risk of CHD events manifested by CHD deaths or
nonfatal MI. The lack of effect on CHD in that study might have
been due to the limited reduction in SFA intake and concomitant
reduced intake of unsaturated fatty acids, which resulted in
a limited decrease in the LDL-cholesterol concentration. One
follow-up study found an inverse association between intake of
PUFAs and risk of CHD deaths (23). That study, however, did
not address the difference in risk of a lower energy intake from
SFAs and a concomitant higher energy intake from PUFAs, but
the difference in risk of a higher energy intake from PUFAs,
independent of energy intake from SFAs. Another follow-up
study examined the risk of CHD for a lower energy intake from
SFAs and a concomitant higher energy intake from unsaturated
fatty acids or carbohydrates (4). The results from that study
showed that replacing SFAs with unsaturated fatty acids was
inversely associated with risk of CHD, whereas replacing SFAs
with carbohydrates was not associated with risk of CHD. The
present study, however, cannot be considered independent of
that study because the present study was partly based on the
same participants. The beneficial effect of replacing SFAs with
unsaturated fatty acids is also in line with time trend data from
Poland, where mortality due to CHD has decreased in parallel
with an increase in PUFA intake and with a decrease in SFA
intake between 1990 and 1999 (24). Thus, the present results
TABLE 2
Combined hazard ratios (HRs) for coronary events and coronary deaths per 5% increments in energy intake from polyunsaturated fatty acids (PUFAs) or
carbohydrates (CHs) in the Pooling Project of Cohort Studies on Diet and Coronary Disease1
All Women Men
HR (95% CI)
P value, test for
between-studies
heterogeneity HR (95% CI)
P value, test for
between-studies
heterogeneity HR (95% CI)








Model 13 1.39 (1.20, 1.61) 1.33 (1.01, 1.74) 1.47 (1.25, 1.73)
Model 24 1.19 (1.00, 1.42) 0.32 1.15 (0.84, 1.58) 0.30 1.23 (0.98, 1.55) 0.32 0.49
PUFAs for SFAs
Model 13 0.69 (0.59, 0.81) 0.66 (0.54, 0.81) 0.68 (0.52, 0.87)
Model 24 0.87 (0.77, 0.97) 0.70 0.85 (0.68, 1.06) 0.51 0.87 (0.76, 1.01) 0.61 0.84
CHs for SFAs
Model 13 1.06 (1.01, 1.12) 0.98 (0.90, 1.06) 1.10 (1.05, 1.16)
Model 24 1.07 (1.01, 1.14) 0.51 1.00 (0.89, 1.12) 0.72 1.11 (1.02, 1.20) 0.37 0.13
Coronary deaths5
MUFAs for SFAs
Model 13 1.16 (0.83, 1.60) 0.97 (0.62, 1.52) 1.31 (0.82, 2.09)
Model 24 1.01 (0.73, 1.41) 0.18 0.88 (0.51, 1.54) 0.27 1.10 (0.71, 1.69) 0.18 0.40
PUFAs for SFAs
Model 13 0.57 (0.42, 0.77) 0.51 (0.29, 0.89) 0.64 (0.46, 0.90)
Model 24 0.74 (0.61, 0.89) 0.40 0.61 (0.37, 1.01) 0.14 0.80 (0.64, 0.99) 0.81 0.24
CHs for SFAs
Model 13 0.93 (0.82, 1.06) 0.85 (0.68, 1.07) 1.00 (0.86, 1.15)
Model 24 0.96 (0.82, 1.13) 0.05 0.86 (0.65, 1.13) 0.16 1.03 (0.86, 1.24) 0.14 0.08
1 MUFAs, monounsaturated fatty acids; SFAs, saturated fatty acids.
2 n ¼ 306,244 for all; n ¼ 215,006 for women; and n ¼ 91,238 for men.
3 Model 1 included intake of MUFAs, PUFAs, trans fatty acids, protein, and CHs expressed as percentages of total energy intake (as continuous variables)
and total energy intake (kcal/d) (as a continuous variable). Age at baseline (y) and the calendar year in which the baseline questionnaire was returned were
entered into the model through the strata statement. Within each study, HRs with 95% CIs for the incidence of a coronary event and of mortality from coronary
heart disease were calculated by using Cox proportional hazards regression with time in study (y) as the time metric. The study-specific logs of HRs were
weighted by the inverse of their variances, and a combined estimate of the HRs was computed by using a random-effects model. The estimated HRs for
unsaturated fatty acids and CHs can be interpreted as the estimated differences in risk of a 5% lower energy intake from SFAs and a concomitant higher energy
intake from unsaturated fatty acids and CHs, respectively.
4 Model 2 included variables in model 1 and smoking (never smokers, former smokers, or current smoker of 1–4, 5–14, 15–24, or 25 cigarettes/d), BMI
(in kg/m2; ,23, 23 to ,25, 25 to ,27.5, 27.5 to ,30, or 30), physical activity (levels 1–5), highest attained educational level (,high school, high school,
or .high school), alcohol intake (0, 0 to ,5, 5 to ,10, 10 to ,15, 15 to ,30, 30 to ,50, or 50 g/d), history of hypertension (yes or no), and energy-adjusted
quintiles of fiber intake (g/d) and cholesterol intake (mg/d). The estimated HRs for unsaturated fatty acids and CHs can be interpreted as the estimated
differences in risk of a 5% lower energy intake from SFAs and a concomitant higher energy intake from unsaturated fatty acids and CHs, respectively.
5 n ¼ 327,660 for all; n ¼ 228,150 for women; and n ¼ 99,510 for men.
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that suggest that replacing SFAs with PUFAs may have a greater
benefit than replacing SFAs with carbohydrates are in agreement
with previous studies.
Substitution of MUFAs for SFAs decreases plasma LDL-
cholesterol concentration (25). The indication of an increased
risk of CHD associated with a lower intake of SFAs and a con-
comitant higher energy intake from MUFAs may be due in part
to intake of TFAs, which is included in the sum of MUFAs.
However, all study-specific HRs of MUFA intake and risk of
CHD were adjusted for TFA intake with the exception of the
study-specific HRs from the AHS, the Glostrup Population Study,
and the IIHD because information on TFA intake was not
available for participants from these cohort studies. Further-
more, in analyses only including participants from the 8 cohort
studies (ARIC, ATBC, FMC, Health Professionals Follow-Up
Study, IWHS, Nurses’ Health Study 1980, Nurses’ Health Study
1986, VIP, and WHS), for whom information on intake of TFAs
was available, adjustment for TFAs did not change the combined
HRs (data not shown). The adjustment for TFAs, however, is
highly probable to have been incomplete because of industrial
modification of the content of TFAs in foods during the time
period of the follow-up of the participants. Other mechanisms
than reduced LDL-cholesterol concentration, however, may be
involved (26). Finally, it should be mentioned that the main
FIGURE 1. Study-specific and combined hazard ratios and 95% CIs for coronary events (A) (n ¼ 306,244) and coronary deaths (B) (n ¼ 327,660) in the
Pooling Project of Cohort Studies on Diet and Coronary Disease. The model included intake of monounsaturated fatty acids, polyunsaturated fatty acids
(PUFAs), trans fatty acids, carbohydrates (CHs), and protein expressed as percentages of total energy intake (E%; as continuous variables), total energy intake
(kcal/d; as a continuous variable), smoking (never smokers, former smokers, or current smoker of 1–4, 5–14, 15–24, or 25 cigarettes/d), BMI (in kg/m2;
,23, 23 to ,25, 25 to ,27.5, 27.5 to ,30, or 30), physical activity (levels 1–5), highest attained educational level (,high school, high school, or .high
school), alcohol intake (0, 0 to ,5, 5 to ,10, 10 to ,15, 15 to ,30, 30 to ,50, or 50 g/d), history of hypertension (yes or no), and energy-adjusted quintiles
of fiber intake (g/d) and cholesterol intake (mg/d). Age at baseline (y) and the calendar year in which the baseline questionnaire was returned (y) were entered
into the model through the strata statement. Within each study, hazard ratios with 95% CIs for the incidence of a coronary event and of mortality from
coronary heart disease were calculated by using Cox proportional hazards regression with time in study (y) as the time metric. The study-specific logs of
hazard ratios were weighted by the inverse of their variances, and a combined estimate of the hazard ratios was computed by using a random-effects model.
The estimated hazard ratios for PUFAs and CHs can be interpreted as the estimated differences in risk of a 5% lower energy intake from saturated fatty acids
(SFAs) and a concomitant higher energy intake from PUFAs and CHs, respectively. The squares and horizontal lines represent the study-specific hazard ratios
and 95% CIs, respectively. The area of the squares reflects the study-specific weight (inverse of the variance). The diamonds represent the combined hazard
ratios and 95% CI. AHS, Adventis Health Study; ARIC, Atherosclerosis Risk in Communities Study; ATBC, Alpha-Tocopherol and Beta-Carotene Cancer
Prevention Study; FMC, Finnish Mobile Clinic Health Study; GPS, Glostrup Population Study; HPFS, Health Professionals Follow-Up Study; IIHD, Israeli
Ischemic Heart Disease Study; IWHS, Iowa Women’s Health Study; NHSa, Nurses’ Health Study 1980; NHSb, Nurses’ Health Study 1986; VIP, Västerbotten
Intervention Program; WHS, Women’s Health Study.






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DIETARY FAT AND CORONARY HEART DISEASE 1431
source of MUFAs was animal fat, whereby confounding from
other dietary components in meat and dairy products cannot be
excluded.
It has been suggested that the association between major types
of fat and risk of CHD is modified by sex and age (5, 27–30). This
study suggests that to prevent CHD, SFAs should be reduced and
replaced with PUFAs among all middle-aged and older women
and men. However, it cannot be excluded that associations may
be stronger in subgroups, but our study only provides a sugges-
tion for these possibilities.
In conclusion, the associations found in this study suggest that
replacing SFA intake with PUFA intake rather than MUFA or
carbohydrate intake prevents CHD over a wide range of intakes
and among all middle-aged and older women and men.
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